All Title Author
Keywords Abstract

Hemophagocytic Syndrome Associated with Mycoplasma pneumoniae Pneumonia

DOI: 10.1155/2013/586705

Full-Text   Cite this paper   Add to My Lib


Mycoplasma pneumoniae (Mp) sometimes causes immunological complications in children. We present a rare case of hemophagocytic syndrome (HPS) caused by Mp in a previously healthy 7-year-old Japanese girl. A chest radiograph obtained to evaluate the source of her fever showed infiltration in the lower right lung with mild splenomegaly. We could diagnose the patient with HPS on the basis of the hemophagocytic-lymphohistiocytosis- (HLH) 2004 criteria. She met the criteria for fever, splenomegaly, neutrophil count (<1,000/μL), platelet count (<10.0?×?104/μL), fasting triglyceride level (>265?mg/dL), and ferritin level (>500?ng/mL). Furthermore, a peripheral blood smear showed an increased number of monocytes/macrophages with erythrophagocytosis. Treatment with clarithromycin and prednisolone, which was initiated soon after the diagnosis, was successful. Mp infection might partly progress to HPS in certain conditions. Clinicians should be aware of HPS caused by Mp and start appropriate treatment as soon as possible if the disease is suspected. 1. Introduction Mycoplasma pneumoniae (Mp) is well known to cause upper and lower respiratory tracts infections, including pharyngitis, bronchitis, and pneumonia. Mp also causes immunological complications in children, such as Stevens-Johnson syndrome, Guillain-Barré syndrome, Kawasaki disease [1], aseptic meningitis, and hemophagocytic syndrome (HPS). HPS is characterized by abnormal activation of monocytes/macrophages and consequently overproduction of proinflammatory cytokines [2, 3]. Among various types of HPS, secondary HPS is often associated with infections such as virus, bacteria, fungi, and parasites [4]. However, Mp rarely causes secondary HPS, and there have so far been few reports concerning HPS due to Mp [5, 6]. We herein report a 7-year-old girl who was diagnosed as having HPS associated with Mp pneumonia, and we successfully treated her with an appropriate antibiotic along with corticosteroid soon after the diagnosis. 2. Case Presentation A previously healthy 7-year-old Japanese girl presented to her physician with three-day history of fever, cough, and malaise and was referred to our outpatient clinic by the physician for evaluation of fever and leukocytopenia. Physical examinations revealed mild hepatosplenomegaly, however, no lymphadenopathy nor skin rash. Chest auscultation revealed also normal breath sounds. A chest radiograph obtained to evaluate the source of her fever showed infiltration in the lower right lung with mild splenomegaly (Figure 1). Laboratory findings were as follows: white blood


[1]  Y. Kobayashi, Y. Koike, T. Tokutomi, Y. Kuroki, and I. Todoroki, “Fever, rash and pulmonary involvement,” Acta Paediatrica, vol. 95, no. 9, pp. 1146–1148, 2006.
[2]  G. E. Janka, “Hemophagocytic syndromes,” Blood Reviews, vol. 21, no. 5, pp. 245–253, 2007.
[3]  S. Imashuku, “Advances in the management of hemophagocytic lymphohistiocytosis,” International Journal of Hematology, vol. 72, no. 1, pp. 1–11, 2000.
[4]  J.-I. Henter, A. Horne, M. Aricó et al., “HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis,” Pediatric Blood and Cancer, vol. 48, no. 2, pp. 124–131, 2007.
[5]  M. Yoshiyama, S. Kounami, K. Nakayama, N. Aoyagi, and N. Yoshikawa, “Clinical assessment of Mycoplasma pneumoniae-associated hemophagocytic lymphohistiocytosis,” Pediatrics International, vol. 50, no. 4, pp. 432–435, 2008.
[6]  Y. Ishida, K. Hiroi, H. Tauchi, Y. Oto, K. Tokuda, and K. Kida, “Hemophagocytic lymphohistiocytosis secondary to Mycoplasma pneumoniae infection,” Pediatrics International, vol. 46, no. 2, pp. 174–177, 2004.
[7]  Y. Osugi, J. Hara, S. Tagawa et al., “Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis,” Blood, vol. 89, no. 11, pp. 4100–4103, 1997.
[8]  T. Oishi, M. Narita, K. Matsui et al., “Clinical implications of interleukin-18 levels in pediatric patients with Mycoplasma pneumoniae pneumonia,” Journal of Infection and Chemotherapy, vol. 17, no. 6, pp. 803–806, 2011.
[9]  A. Tamura, K. Matsubara, T. Tanaka, H. Nigami, K. Yura, and T. Fukaya, “Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children,” Journal of Infection, vol. 57, no. 3, pp. 223–228, 2008.
[10]  C. Tagliabue, C. M. Salvatore, C. Techasaensiri et al., “The impact of steroids given with macrolide therapy on experimental Mycoplasma pneumoniae respiratory infection,” Journal of Infectious Diseases, vol. 198, no. 8, pp. 1180–1188, 2008.
[11]  R. Mizukane, J.-I. Kadota, T. Yamaguchi et al., “An elderly patient with hemophagocytic syndrome due to severe Mycoplasma pneumonia with marked hypercytokinemia,” Respiration, vol. 69, no. 1, pp. 87–91, 2002.


comments powered by Disqus

Contact Us


微信:OALib Journal